Sign in Create account

Gian Life Care Limited

Healthcare · Healthcare Services

BSE: 542918
₹4.71
▲ 0.02 (0.43%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
46/100
Moderate
Valuation
—/100
Data unavailable
Momentum
43/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-72.0
Free Cash Flow
₹0 Cr
as of March 31, 2025
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-421.43%
as of Sept. 30, 2025
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-104.27%
as of Dec. 31, 2025
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
-62.82%
as of Dec. 31, 2025
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-48.11%
as of June 30, 2025
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
-29.33%
as of Dec. 31, 2025
Industry median 18.84% (52 companies)
Current Ratio
1.45
as of March 31, 2025
Industry median 2.06 (74 companies)
Debt to Equity
0.30
as of March 31, 2025
Industry median 0.11 (62 companies)
Interest Coverage
-0.83
as of Dec. 31, 2025
Industry median 7.94 (57 companies)
Net Margin
6.34%
as of June 30, 2025
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
20.38%
as of Dec. 31, 2025
Industry median 17.21% (61 companies)
Operating Margin (TTM)
-9.41%
as of Dec. 31, 2025
Industry median 16.20% (59 companies)
Return on Assets
5.54%
as of March 31, 2025
Industry median 5.40% (58 companies)
Return on Capital Employed
3.00%
as of March 31, 2025
Industry median 10.44% (56 companies)
Return on Equity
9.97%
as of March 31, 2025
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 5 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.30)
  • No Return on equity is 15% or more (10.0%)
  • Yes Net cash flow for the latest year is positive

Ownership

1 of 2 met
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.4%
Low 4.5300 · High 4.7900
1W return
-0.6%
Low 4.4900 · High 4.7900
1M return
-2.5%
Low 4.4900 · High 4.9400
52W return
-74.8%
Low 4.4900 · High 5.0800
Lifetime High ₹138.9500 (Feb. 17, 2022)
Lifetime Low ₹4.5100 (Sept. 28, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
4.7
10D
4.7
20D
5.0
50D
8.2
100D
12.3
200D
18.2

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

4.68
Pivot
First resistance4.82
Second resistance4.94
Third resistance5.08
First support4.56
Second support4.42
Third support4.30
Day RSI29.4
Day MFI43.2
Day MACD-0.83
Day MACD signal-1.15

Beta

1M0.47
3M-0.19
1Y-0.19
3Y0.44

Price change analysis

↓ -2.5%
Over 1 Month
LowHigh
4.494.94
↓ -74.8%
Over 3 Months
LowHigh
4.495.08
↓ -74.8%
Over 6 Months
LowHigh
4.495.08
↓ -74.8%
Over 1 Year
LowHigh
4.495.08
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (Dec. 31, 2025)
₹1 Cr
Net profit (Dec. 31, 2025)
₹— Cr
Basic EPS (Dec. 31, 2025)
₹0.1200

Ranks #None of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter30.17%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 32.09% to 30.17% in Mar 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 174 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
13 Mar 2026 BRAHMA HOSPITAL HUF Bulk Buy 67,690 7.6100 BSE
13 Mar 2026 HARISH KUMAR Bulk Sell 67,690 7.6100 BSE
17 Mar 2025 TEJESH HASMUKH SHAH Bulk Buy 58,155 17.9200 BSE
7 Feb 2025 HARISH KUMAR Bulk Buy 80,000 16.7600 BSE
29 Nov 2024 ARUN KUMAR GUPTA Bulk Buy 65,217 19.6600 BSE
28 Nov 2024 ARUN KUMAR GUPTA Bulk Sell 62,000 18.3600 BSE
4 Nov 2024 ARUN KUMAR GUPTA Bulk Buy 70,000 22.2000 BSE
31 Oct 2024 ARUN KUMAR GUPTA Bulk Sell 70,000 18.1600 BSE
13 Sep 2024 PRAGNESH ROHITKUMAR PANDYA Bulk Sell 60,741 22.9300 BSE
13 Sep 2024 PRAGNESH ROHITKUMAR PANDYA Bulk Buy 60,741 22.9900 BSE

All bulk and block deals →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (10.0%)
  • Declining revenue YoY (-29.3%)
  • Declining profit YoY (-48.1%)

Opportunities

  • RSI in oversold territory (29.4) -- a technical rebound zone

Threats

  • Down 74.8% over the past year
  • Weak interest coverage (-0.8x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Gian Life Care Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.